Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Double-Dummy, Active Comparator, Multicenter Study to Evalute the Efficacy and Safety of Rituximab versus MMF in patients with Pemphigus Vulgaris

Project: Research

Project Details

StatusFinished
Effective start/end date12/4/15 → 08/31/20

Funding

  • Genentech Incorporated: $77,769.00